Marin Sekosan, MD

Tagged with
Marin Sekosan, MD
Specialties: Anatomic & Clinical Pathology
General surgical pathology with emphasis on lung, breast, urological, and vascular pathology
Location(s): John H. Stroger, Jr. Hospital
Provident Hospital
Department/Division: Pathology
Faculty Rank: System Chair, Department of Pathology CCHHS; Chair, Division of Anatomic Pathology, John H. Stroger, Jr. Hospital of Cook County; Clinical Professor of Pathology, University of Illinois at Chicago
Board Certification: Anatomic and Clinical Pathology
Medical Education: University of Sarajevo
Residency: Anatomic and Clinical Pathology, Rhode Island Hospital, Brown University & University of Illinois at Chicago
Fellowship: Surgical Pathology, University of Illinois at Chicago
Research Interest: Lung, breast and prostate
Publications: Dragovic T. Sekosan M, Becker P R, and Erdos G E, Detection of Neutral Endopeptidase 24.11 (Neprisylin) in Human Hepatocellular Carcinoma by Immunohistochemistry. Anticancer Research 17:3232-3238 (1997).
Sekosan M, Schraufnagel ED. Staining tissue with methacrylate casts for light microscopy. Scanning, 1998;20:508-10.
Dagar S, Sekosan M, Blend M, Rubinstein I, Onyuksel H. Identification and targeting of VIP receptors in rats with chemical induced breast cancer. Proceed Intl. Control Rel. Bioact. Mat.1999; 26:22-23.
Barnett VT, Sekosan M, Khurshid A. Wegner's Granulomatosis and Alpha Antitrypain Deficiency Emphysema: Proteinase Related Diseases. Chest 1999 116:253-5. Sekosan M, Blanchard J, Massad M, and Benedetti E. Rejection pattern of simultaneously transplanted cardiac and skeletal muscle in a rat model. International Journal of Surgical Investigation Vol. 1, No. 3, pp. 237-243, 2000.
Dagar S, Sekosan M, Rubinstein I, Onyuksel H. Detection of VIP receptors in MNU-induced breast cancer in rats: Implications for breast cancer targeting. Breast Cancer Research and Treatment 65: 49,2001.
Dagar S, Sekosan M, Lee B, Rubinstein I, Onyuksel H. VIP receptors as molecular targets of breast cancer: Implications for targeted delivery. J Controlled Release. 2001 Jul 6;74(1-3):129-34.
Ramirez AM, Takaguwa S, Sekosan M, Jaffe AH, Varga J, and Roman J. Smad3 Deficiency Ameliorates Experimental Obliterative Bronchiolitis in a Heterotopic Tracheal Transplantation Model. Amerian Journal of Pathology, 2004;165:1223-1232.
Ashkenazi I, Ferrer K, Sekosan M, Marcus E, Bork J, Aiti T, Lavy R, Zaren HA. Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions. Am J Surg. 2007 Aug, 194(2):183-8.
Dookeran AK, Dignam JJ, Ferrer K, Sekosan M, McCaskill-Stevens W and Gehert S. p53 as a Marker of Prognosis in African-American Women with Breast Cancer. Annals of Surgical Oncology 2010; 17(5):1398-405.
Dagar A, Kuzmis A, Rubinstein I, Sekosan M and Onyusel H VIP-targeted Cytotoxic Nanomedicine for Breast Cancer. Drug Deliv Trans Res 2012 1:2 (6):454-462.
Hakemi E, Bero J, Sekosan M and Ansari A. Non-valvular right atrial papillary fibroelastoma: Case report and case review. The Journal of Thoracic and Cardiovascular Surgery 2013; 28. doi;pii:s0022-5223(13)00275-4. 1016/j.jtcvs.2013.02.077. [Epup ahead of print].